Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00383604 · ClinicalTrials.gov registry record
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 30
- Enrollment target
NCT00383604: Completed study, sponsored by Stanford University.
NCT00383604 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00383604 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
To better understand the mechanisms leading to lymphedema development in breast cancer survivors, and the implications for potential innovative approaches to the screening, prevention and treatment of this condition.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-07 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00383604
The ClinicalTrials.gov registry entry for NCT00383604 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00383604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00383604 about?
NCT00383604 is a clinical study titled "Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2". To better understand the mechanisms leading to lymphedema development in breast cancer survivors, and the implications for potential innovative approaches to the screening, prevention and treatment of this condition.
What is the current status of trial NCT00383604?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2005-07. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT00383604?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.